KALVISTA PHARMACEUTICALS INC (KALV) Stock Balance Sheet
NASDAQ:KALV • US4834971032
Current stock price
20.13 USD
+1.77 (+9.64%)
At close:
20.51 USD
+0.38 (+1.89%)
Pre-Market:
| MRQ (2025-9-30) | 2025 (2025-12-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 243.50M | 131.62M | 31.79M | 56.20M | 30.70M | |||
| Marketable Securities | 65.66M | 89.00M | 178.61M | 93.10M | 135.50M | |||
| Receivables | 7.12M | 4.14M | 10.87M | 18.60M | 14.10M | |||
| Inventories | 458.00K | 3.43M | N/A | N/A | N/A | |||
| Other Current Assets | 8.49M | 16.93M | 4.42M | 4.30M | 13.30M | |||
| Total Current Assets | 325.23M | 241.69M | 225.69M | 172.30M | 193.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.29M | 7.53M | 9.15M | 10.80M | 10.00M | |||
| Other Non-Current Assets | 2.42M | 1.55M | 567.00K | 100.00K | 200.00K | |||
| Total Non-Current Assets | 14.71M | 9.08M | 9.71M | 10.90M | 10.30M | |||
| TOTAL ASSETS | 339.93M | 250.77M | 235.40M | 183.20M | 203.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.29M | 13.57M | N/A | N/A | N/A | |||
| Accrued Expenses | 22.20M | 29.28M | 13.70M | 10.20M | 7.90M | |||
| Accounts Payable | 8.07M | 4.88M | 9.11M | 4.80M | 3.60M | |||
| Other Current Liabilities | 11.51M | 11.00M | N/A | N/A | N/A | |||
| Total Current Liabilities | 45.07M | 45.17M | 22.81M | 15.00M | 11.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 268.74M | 105.88M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 9.13M | 4.33M | 6.01M | 7.10M | 7.20M | |||
| Total Non-Current Liabilities | 277.86M | 110.21M | 6.01M | 7.20M | 7.20M | |||
| TOTAL LIABILITIES | 322.93M | 155.38M | 28.82M | 22.20M | 18.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -739.10M | -653.17M | -469.73M | -343.10M | -250.20M | |||
| Additional Paid In Capital | 762.78M | 753.73M | 679.75M | 507.10M | 439.10M | |||
| Common Shares | 50.00K | 50.00K | 42.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -6.73M | -5.21M | -3.49M | -3.10M | -3.90M | |||
| Shares Outstanding | 50.54M | 49.76M | 42.52M | 34.20M | 24.60M | |||
| Tangible Book Value per Share | 0.34 | 1.92 | 4.86 | 4.71 | 7.52 | |||
| Total Shareholders' Equity | 17.00M | 95.39M | 206.58M | 161.00M | 185.10M | |||
| TOTAL LIABILITIES AND EQUITY | 339.93M | 250.77M | 235.40M | 183.20M | 203.90M | |||
| Statistics | ||||||||
| Debt/Equity | 15.81 | 1.11 | N/A | N/A | N/A | |||
| Current Ratio | 7.22 | 5.35 | 9.90 | 11.49 | 16.69 | |||
| Return On Assets (ROA) | -32.26% | -43.68% | -53.80% | -50.72% | -40.38% | |||
| Return On Equity (ROE) | -645.16% | -114.82% | -61.30% | -57.71% | -44.48% | |||
All data in USD , ROIC based on taxRate of 0.21